Literature DB >> 19675531

Dopamine D1 receptor (DRD1) genetic polymorphism: pleiotropic effects on heritable renal traits.

Maple M Fung1, Brinda K Rana, Chih-Min Tang, Tetsuo Shiina, Caroline M Nievergelt, Fangwen Rao, Rany M Salem, Jill Waalen, Michael G Ziegler, Paul A Insel, Daniel T O'Connor.   

Abstract

Because dopamine D(1) receptors (DRD1) influence renal sodium transport and vascular hemodynamics, we examined whether genetic polymorphisms play a role in renal function. We conducted polymorphism discovery across the DRD1 open reading frame and its 5'-UTR and then performed association studies with estimated glomerular filtration rate (eGFR), plasma creatinine (pCr), and fractional excretion of uric acid (FeUA). We used a twin/family group of 428 subjects from 195 families and a replication cohort of 677 patients from the Kaiser health-care organization sampled from the lower percentiles of diastolic blood pressures. Although the coding region lacked common non-synonymous variants, we identified two polymorphisms in the DRD1 5'-UTR (G-94A, A-48G) that occurred with frequencies of 15 and 30%, respectively. In the twin/family study, renal traits were highly heritable, such that DRD1 G-94A significantly associated with eGFR, pCr, and FeUA. Homozygotes for the G-94A minor allele (A/A) exhibited lower eGFR, higher pCr, and lower FeUA. No effects were noted for DRD1 A-48G. Patients in the Kaiser group had similar effects of G-94A on eGFR and pCr. Kidney cells transfected with the -94A variant but not the wild type vectors had increased receptor density. Because the -94A allele is common and may reduce glomerular capillary hydrostatic pressure, G-94A profiling may aid in predicting survival of renal function in patients with progressive renal disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19675531      PMCID: PMC2803094          DOI: 10.1038/ki.2009.306

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  58 in total

1.  Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4.

Authors:  Jan A Staessen; Tatiana Kuznetsova; Haifeng Zhang; Marc Maillard; Murielle Bochud; Sandra Hasenkamp; Judith Westerkamp; Tom Richart; Lutgarde Thijs; Xinli Li; Stefan-Martin Brand-Herrmann; Michel Burnier; Eva Brand
Journal:  Hypertension       Date:  2008-04-14       Impact factor: 10.190

2.  Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status.

Authors:  D P O'Connell; N V Ragsdale; D G Boyd; R A Felder; R M Carey
Journal:  Hypertension       Date:  1997-01       Impact factor: 10.190

3.  Dopamine depolarizes podocytes via a D1-like receptor.

Authors:  M Bek; K G Fischer; S Greiber; C Hupfer; P Mundel; H Pavenstädt
Journal:  Nephrol Dial Transplant       Date:  1999-03       Impact factor: 5.992

4.  Renal albumin excretion: twin studies identify influences of heredity, environment, and adrenergic pathway polymorphism.

Authors:  Fangwen Rao; Jennifer Wessel; Gen Wen; Lian Zhang; Brinda K Rana; Brian P Kennedy; Tiffany A Greenwood; Rany M Salem; Yuqing Chen; Srikrishna Khandrika; Bruce A Hamilton; Douglas W Smith; Niels-Henrik Holstein-Rathlou; Michael G Ziegler; Nicholas J Schork; Daniel T O'Connor
Journal:  Hypertension       Date:  2007-03-12       Impact factor: 10.190

5.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

6.  Population-based sample reveals gene-gender interactions in blood pressure in White Americans.

Authors:  Brinda K Rana; Paul A Insel; Samuel H Payne; Kenneth Abel; Ernest Beutler; Michael G Ziegler; Nicholas J Schork; Daniel T O'Connor
Journal:  Hypertension       Date:  2006-12-11       Impact factor: 10.190

7.  Heritability of daytime ambulatory blood pressure in an extended twin design.

Authors:  Nina Kupper; Gonneke Willemsen; Harriëtte Riese; Daniëlle Posthuma; Dorret I Boomsma; Eco J C de Geus
Journal:  Hypertension       Date:  2004-11-22       Impact factor: 10.190

8.  Studies with fenoldopam, a dopamine receptor DA1 agonist, in essential hypertension.

Authors:  J N Harvey; D P Worth; J Brown; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1986-01       Impact factor: 4.335

Review 9.  Reduction of proteinuria with angiotensin receptor blockers.

Authors:  Jan Galle
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-07

Review 10.  Renal blood flow control by tubuloglomerular feedback (TGF) in normal and spontaneously hypertensive rats--a role for dopamine and adenosine.

Authors:  D A Häberle; B Königbauer; M Kawabata; Y Ushiogi
Journal:  Klin Wochenschr       Date:  1991-09-03
View more
  5 in total

Review 1.  Potential dopamine-1 receptor stimulation in hypertension management.

Authors:  Mohammad Asghar; Seyed K Tayebati; Mustafa F Lokhandwala; Tahir Hussain
Journal:  Curr Hypertens Rep       Date:  2011-08       Impact factor: 5.369

Review 2.  Gastrorenal Axis.

Authors:  Pedro A Jose; Robin A Felder; Zhiwei Yang; Chunyu Zeng; Gilbert M Eisner
Journal:  Hypertension       Date:  2016-04-04       Impact factor: 10.190

Review 3.  The Role of the Renal Dopaminergic System and Oxidative Stress in the Pathogenesis of Hypertension.

Authors:  Waleed N Qaddumi; Pedro A Jose
Journal:  Biomedicines       Date:  2021-02-01

4.  Association of dopamine D1 receptor gene polymorphism with schizophrenia: a meta-analysis.

Authors:  Yuqing Pan; Jun Yao; Baojie Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2014-06-20       Impact factor: 2.570

5.  Renal oxidative stress induced by long-term hyperuricemia alters mitochondrial function and maintains systemic hypertension.

Authors:  Magdalena Cristóbal-García; Fernando E García-Arroyo; Edilia Tapia; Horacio Osorio; Abraham S Arellano-Buendía; Magdalena Madero; Bernardo Rodríguez-Iturbe; José Pedraza-Chaverrí; Francisco Correa; Cecilia Zazueta; Richard J Johnson; Laura-Gabriela Sánchez Lozada
Journal:  Oxid Med Cell Longev       Date:  2015-03-31       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.